Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that Matthew W. Foehr has been promoted to President and Chief Operating Officer. Previously Mr. Foehr served as the Company’s Executive Vice President and Chief Operating Officer. John Higgins, who had been serving as President and Chief Executive Officer, will continue to serve as the Company’s Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
